Posted by A Special issue “Drug-Cyclodextrin Interactions. A Basis for New Formulations” in Molecules (ISSN 1420-3049, http://www.mdpi.com/journal/molecules) will be published. Contributions of either an original research paper, a short communication, or a focus review are expected to this issue.
The deadline for paper submissions is 31 December 2021.
Website: https://www.mdpi.com/journal/molecules/special_issues/drug_cyclodextrin
Special Issue Editors
Prof. Dr. Thomas Mavromoustakos
Department of Chemistry, National & Kapodistrian University of Athens, Greece
Interests: hypertension; structure elucidation; nuclear magnetic resonance; spectroscopy; NMR spectroscopy; medicinal and pharmaceutical chemistry; molecular modeling; Raman spectroscopy; DSC; NMR structure elucidation
Assoc. Prof. Dr. Andreas Tzakos
Department of Chemistry, University of Ioannina, Ioannina, Greece
Interests: development of tumor-homing and tumor-responsive drug delivery vehicles as theranostics; drug formulations and prodrugs; development of imaging agents for visualizing and charting cellular compartments; pharmacokinetics (LC-MS, HPLC-based) and bioactivity evaluation; design and development of cancer diagnostics and theranostics; development of tumor-homing probes equipped with multimodal imaging agents (for MRI, in vivo near-infrared I & II optical imaging, and SPECT/PET probes)
Prof. Dr. Georgia N. Valsami
Department of Pharmacy, National & Kapodistrian University of Athens, Greece
Interests: drug-protein binding; drug-cyclodextrins interaction, characterization and effect on drug solubility/dissolution/absorption; Development and in vitro-in vivo evaluation of novel dosage forms with optimized absorption (GI/nasal/pulmonary); PK/PD studies and dosage individualization
Molecules is the leading international peer-reviewed open access journal of chemistry. Molecules is published semi-monthly online by MDPI—the largest fully open-access publisher in the world. Molecules has received an updated Journal Impact Factor of 3.267 in the June 2020 release of Journal Citation Reports®. Molecules now ranks 70/177 (Q2) in the category ‘Chemistry, Multidisciplinary’ and 141/297 (Q2) in ‘Biochemistry and Molecular Biology’. Molecules ranks Q1 in the SCImago Journal Rank (SJR) category “Pharmaceutical Sciences”.
Author Benefits
Fast manuscript handling time—A first decision is provided to authors approximately 12.3 days after submission; acceptance to publication is then undertaken in 2.5 days.
High visibility: indexed by the Science Citation Index Expanded (Web of Science), MEDLINE (PubMed), Scopus, and other databases.